000 01242 a2200373 4500
005 20250517225845.0
264 0 _c20190814
008 201908s 0 0 eng d
022 _a1468-3288
024 7 _a10.1136/gutjnl-2018-316845
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVerstockt, Bram
245 0 0 _aTREM-1, the ideal predictive biomarker for endoscopic healing in anti-TNF-treated Crohn's disease patients?
_h[electronic resource]
260 _bGut
_c08 2019
300 _a1531-1533 p.
_bdigital
500 _aPublication Type: Letter; Research Support, Non-U.S. Gov't; Comment
650 0 4 _aAdalimumab
650 0 4 _aBiomarkers
650 0 4 _aBiopsy
650 0 4 _aCrohn Disease
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aTriggering Receptor Expressed on Myeloid Cells-1
650 0 4 _aTumor Necrosis Factor-alpha
700 1 _aVerstockt, Sare
700 1 _aBlevi, Helene
700 1 _aCleynen, Isabelle
700 1 _ade Bruyn, Magali
700 1 _aVan Assche, Gert
700 1 _aVermeire, Séverine
700 1 _aFerrante, Marc
773 0 _tGut
_gvol. 68
_gno. 8
_gp. 1531-1533
856 4 0 _uhttps://doi.org/10.1136/gutjnl-2018-316845
_zAvailable from publisher's website
999 _c28632190
_d28632190